PRESS RELEASE
FOR IMMEDIATE RELEASE
February 14, 2024
[WASHINGTON, DC] – Citizens for a Secure and Safe America (C4SSA) praises today’s passage of the bipartisan Assad Regime Anti-Normalization Act (H.R. 3202) in the House of Representatives. The bill, which combats normalization with the Assad regime, passed by a vote of [389-32].
“The Assad Regime Anti-Normalization Act is a vital tool to press countries which are warming up to the brutal Assad regime. I would like to thank the House of Representatives for passing this critical legislation,” said Muhammad Bakr Ghbeis, President of C4SSA.
The Assad Regime Anti-Normalization Act (H.R. 3202) comes as a long overdue response to the wave of normalization with the Assad regime that took place throughout the past year. The regional effort to reengage with the pariah state granted Assad a seat at the Arab League, ultimately undermining the pursuit of peace, justice, and accountability. This newly passed bill, however, aims to put an end to normalization with the criminal Assad regime.
This bipartisan bill would prohibit the United States federal government from recognizing or normalizing relations with any Syrian government led by Assad and expand sanctions available under the “Caesar Syria Civilian Protection Act of 2019” to combat normalization by other countries. The bill includes several modifications to the Caesar Act that would ensure continued humanitarian aid to the Syrian people by closing loopholes used by the regime to evade consequences and sanction those involved in diverting or stealing humanitarian aid.
Additionally, the bill requires the US government to actively oppose normalization by other countries with any government led by Assad. The bill also directs the President to develop an interagency strategy to provide Congress with reports on normalization with the Assad regime as well as the manipulation of the United Nations by the Assad regime.
We commend the representatives who played a crucial role in getting this legislation passed and urge senators to support its swift passage in the upper chamber.
For press inquiries, please contact: [email protected]
